MEHTA VIMAL (CEO, President, Secretary) exercised options at BIOXCEL THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 5/7/2026ACC: 0001104659-26-057367
DirectorOfficer· CEO, President, Secretary
Since Nov 2018
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
18K acquired · 18K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+18K
Price / share
—
Trade value
—
% of position
84.7%
5/1/2026
21.26K→39.26K
Total
Net shares
+18K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/1/2026 | M · Option Exercise | +18K | — | — | 84.7% | 21.26K | 39.26K |
| Total | +18K | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
18K shares
Shares
−18K
Strike price
Held after
0.00
Exercisable
—
5/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock18K shares | 5/1/2026 | M · Option Exercise | −18K | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned125.00
Common Stock
IndirectShares owned480.34K
Total
480.47K indirect480.47K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 125.00 | Indirect |
| Common Stock | 480.34K | Indirect |
| Total | 480.47K | 480.47K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported